Ontario
Mass grave reopens wounds among indigenous survivors of colonial Canadian school system
The discovery of the remains of 215 children at a former residential school in Canada has reopened wounds for survivors of the system, they said, as the government pledged to spend previously promised money to search for more unmarked graves. The Tk’emlúps te Secwépemc indigenous nation in British Columbia announced last week it had found the remains of 215 children, some as young as three, buried at the site of the Kamloops Indian Residential School, once Canada’s largest such school. Between 1831 and 1996, Canada’s residential school system forcibly separated about 150,000 children from their homes and subjected them to abuse, rape and malnutrition at schools across the country in what the Truth and Reconciliation Commission in 2015 called “cultural genocide”. Run by the government and c...
US election: Republicans hold back Democrats, narrowing path to Senate control
The battle for power in the Senate tightened into Wednesday as Democrats picked up a seat in Colorado, but suffered a setback in Alabama, and Republicans held their own in high-profile races in South Carolina, Iowa, Texas and Kansas, dramatically narrowing the political map. Republicans fought to retain their Senate majority by turning back a surge of Democrats challenging allies of President Donald Trump, and the Democrats’ various paths to seizing control were growing more limited. With several contests still too early to call, and one Georgia race heading to a January runoff, the final verdict is expected to drag on. Democrats gained a seat when ex-Gov. John Hickenlooper ousted GOP Sen. Cory Gardner in Colorado, a must-win to flip the Senate, but couldn’t hold on in Alabama, where forme...
Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine
Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...
